June 5438+1October 65438+1October, 2022, how much does the individual bear per bottle?
In 2022, after medical insurance negotiations, oxytinib was successfully listed in the medical insurance catalogue. The price of a box 1.53 million yuan (80mg×30 tablets), with a drop of 70%, provides the expectation for many lung cancer patients with economic development difficulties to resist lung cancer.
How much is it after the medical insurance reimbursement for osetinib?
At present, the price of Oxitinib Hospital is 5580 yuan, that is, 5580*30%= 1674 yuan, and the rest is 5580- 1674=3906 yuan, 3906*70%=2734.2 yuan and 3906 * 0.3 = according to the national reimbursement ratio. Finally, the total personal burden is1674+1171.8 = 2845.8 yuan. The above reimbursement is calculated according to the new rural cooperative medical system. I hope it will help everyone.
What is the reimbursement rate of imatinib medical insurance?
Legal analysis: Gleevec (Imatinib) was successfully included in the Class B catalogue of national basic medical insurance, industrial injury insurance and maternity insurance (version 20 17), and the payment scope was "limited to patients with chronic myeloid leukemia and Philadelphia chromosome test positive evidence" and "gastrointestinal stromal tumor". After being included in Class B, the reimbursement rate of Gleevec (imatinib) reached about 80% (in different cities), which greatly reduced the treatment burden of patients.
1. If you want to use medical insurance for reimbursement, you must use your own medical insurance card when registering, and the cardholder of the medical insurance card must be yourself;
2. Go to the doctor's office with the registration form just now, the doctor will prescribe medicine, and the patient can pay with the doctor's prescription;
3. Go to the payment window of the hospital, wait for the staff to settle the corresponding expenses, then pay the bill yourself and give the social security card to the staff. The staff will use the social security card to help you reimburse your medical expenses. Many drugs are within the scope of national reimbursement, and some are not within the scope of medical insurance reimbursement, so they must be paid at their own expense.
Information required for reimbursement:
1, outpatient reimbursement information: outpatient invoice, cooperative medical certificate or medical record;
2. Bring all hospitalization reimbursement materials: hospitalization invoice, cooperative medical certificate or medical record, detailed list of expenses, discharge summary and other relevant certificates;
3, outpatient special disease reimbursement data, outpatient invoices, special disease cooperative medical certificate;
4, special disease carrying information, special disease outpatient treatment proposal, cooperative medical certificate, medical records, related laboratory reports and photos.
Legal basis: Regulations of People's Republic of China (PRC) Municipality on Basic Medical Insurance for Urban Workers.
Twenty-eighth personal accounts are used to pay medical expenses beyond the scope of the overall fund; If the personal account is insufficient to pay, it shall be borne by me.
Twenty-ninth serious illness hospitalization medical expenses, according to the following methods to pay:
(a) Qifubiaozhun in principle control in the city, county, autonomous county last year, the average social wage of workers 9%-0%.
(two) the maximum payment limit is controlled in principle at 3-5 times of the average social wage of employees in cities, counties and autonomous counties in the previous year.
(three) medical expenses above the minimum deductible and below the maximum payment limit are mainly paid by the overall fund, and individuals bear a certain proportion. Give appropriate care to the proportion of retirees who bear medical expenses.
The scope of serious diseases, the specific standards of Qifubiaozhun and the maximum payment limit, and the proportion of sharing medical expenses above Qifubiaozhun and below the maximum payment limit shall be determined by the provincial people's government.
Thirtieth medical expenses below Qifubiaozhun and above the maximum payment limit shall not be paid by the overall fund.
Reimbursement rate of medical insurance for Aletinib
Aletinib belongs to Class B drugs, with 5% at its own expense and 95% reimbursed by medical insurance.
Aletinib indications: only for ALK-positive patients with locally advanced or metastatic non-small cell lung cancer.
The proportion of basic medical reimbursement for urban and rural residents who enter the medical insurance except the deductible line is reimbursed according to the level of medical institutions, that is, tertiary medical institutions: 65%, secondary medical institutions in the city: 65% (for those who purchase on the drug recruitment platform and implement the drug zero-difference rate, the reimbursement ratio is+10%), and primary medical institutions: 75% (for those who purchase on the drug recruitment platform and implement the drug zero-difference rate,
Is irutinib included in Shantou medical insurance?
Ibotinib was put on the market in China on 20 17 for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL). Compared with other anticancer drugs, it has faster onset, higher safety and relatively less side effects. But its high price can hardly be absorbed by ordinary people. Therefore, lymphoma patients in China are expecting Ibtinib to enter medical insurance as soon as possible.
In 20 18, China made an innovation in the field of medicine, and the national medical insurance negotiations included 17 new drugs in the medical insurance catalogue, which greatly reduced the prices of these new anticancer drugs. These include Ibtinib, which is imported and distributed by Janssen Company.
Ibotinib has been used in the world for only a few years, but when it entered China and entered the national medical insurance, the price dropped by 68%, from the original 48,600 yuan per box to the present 170 10 yuan per box. After being included in the medical insurance, each bottle in some areas only costs 7000 yuan. This policy has enabled more patients with chronic lymphocytic leukemia and small lymphocytic lymphoma to receive ibotinib treatment.
For patients with chronic lymphoblastic leukemia, whether the condition is critical or there is no effective treatment, taking Ibtinib can prolong their life and gain the right to long-term survival. Leukemia is no longer so terrible, it can become a chronic disease like hypertension and diabetes, and it can maintain long-term survival while ensuring the quality of life.
Ibtinib's inclusion in medical insurance is not only the greatest help to hematologists, but also beneficial to patients. It will certainly become the main drug for treating leukemia and lymphoma.
Does Sichuan Ibtinib have medical insurance? How to reimburse?
Medical insurance is not everything. There are still many high-priced drugs that medical insurance can't report. Imatinib can report 60% in Sichuan.
Afatinib medical insurance reimbursement ratio!
Hello, after 20 18 afatinib was included in medical insurance, the price dropped a lot, and the specific reimbursement ratio of medical insurance was about 50~70% (the reimbursement ratio varies from place to place). After medical insurance reimbursement, the price of a box of afatinib after medical insurance is 1400 yuan, and the specification is 40mgx7 tablets. Afatinib is a class B medical insurance drug, and it can also enjoy 70% medical insurance reimbursement rate. After medical insurance reimbursement, the price of a box of afatinib is only 420 yuan, and the monthly treatment cost is about 6,000 yuan.
Afatinib is a second-generation EGFR targeted drug, which was developed by German pharmaceutical company and introduced to China on 20 17, and is used to treat patients with advanced lung cancer who can't operate or tolerate chemotherapy.
Compared with chemotherapy, the tumor-free survival time of afatinib is 1 1 month, and that of chemotherapy is only 5.6 months. In addition, nearly half (47%) of patients who received alfatinib survived one year after treatment, but only 2% of patients who received chemotherapy maintained this situation. Generally, we can see the advantages of targeted drug (Afatinib) therapy.
After 20 18 and 17 anticancer drugs are included in the medical insurance catalogue, the compensation standard of afatinib medical insurance is: the price of 40mg* tablets is 200 yuan, and patients need to take 40mg of afatinib every day, so the medical expenses for one month are 6,000 yuan; After medical reimbursement, the individual pays about 30%, so the price of afatinib after one-month medical insurance reimbursement is about 1800 yuan.
Conditions for reimbursement of Afatinib medical insurance:
Note: the scope of medical insurance reimbursement for afatinib is limited, and you can only enjoy medical insurance reimbursement if you meet the following two conditions:
Afatinib medical insurance reimbursement conditions: 1 locally advanced or metastatic non-small cell lung cancer (non-small cell lung cancer) with sensitive mutation of epidermal growth factor receptor (EGFR) gene, and had not received treatment with EGFR tyrosine kinase inhibitor (TKI) before; Non-small cell lung cancer (NSCLC) with locally advanced or metastatic squamous histology during or after platinum-containing chemotherapy.
If the above conditions are not met, patients will not be able to enjoy the reimbursement price of afatinib, and they can only choose the original price of 6,000 yuan a month, which is unbearable and unacceptable for ordinary families.
What is the price of oxytinib after it is included in medical insurance?
Hello, after being included in the medical insurance, a box of oxitinib is about 1.5 million yuan, which is a restricted drug use.